查詢結果分析
相關文獻
- Sculptra®-Related Complication in Tear-Trough Treatment--A Case Report
- HELLP Syndrome with Antepartum Pulmonary Edema--A Case Report
- Ephedrine-Induced Complete Atrioventricular Block with Ventricular Asystole during Rapid Concomitant Phenytoin Infusion: A Case Report
- Epiglottic Hematoma Secondary to Endotracheal Intubation
- 臺灣地區慢性脊髓損傷病患排尿處置之調查報告
- 小兒使用TPN引起的併發症
- 淺談糖尿病及其併發症
- 難忘的病人--民俗療法之併發症
- Clinical Experience with Ventricular Endomyocardial Biopsy in Chinese Heart Transplant Patients: A Four-Year Survey of 1,208 Consecutive Procedures
- Subcutaneous Emphysema and Pneumomediastinum Associated with Labor and Delivery
頁籤選單縮合
題 名 | Sculptra®-Related Complication in Tear-Trough Treatment--A Case Report=舒顏萃用於淚溝治療的併發症--個案報告 |
---|---|
作 者 | 陳威儂; 林上熙; 陳柵君; 林煌基; 鄭舉緒; 謝承翰; 林育賢; | 書刊名 | 臺灣整形外科醫學會雜誌 |
卷 期 | 24:4 2015.12[民104.12] |
頁 次 | 頁347-352 |
分類號 | 416.41 |
關鍵詞 | 舒顏萃; 淚溝; 併發症; Sculptra; Sculptra complication; Poly-1-lactic acid complication; Periorbital injection complication; |
語 文 | 英文(English) |
中文摘要 | 背景:舒顏萃是一種聚左旋乳酸產品。自西元1990年於歐洲上市後獲得廣泛地採用,並於西元2004年8月通過美國食品及藥物管理局許可,使用於人類後天免疫缺乏症候群病人之臉部脂肪萎縮。這種刺激型填充劑在台灣應用於臉部美容醫學方面。一位三十歲女性兩年前曾接受過淚溝部位的舒顏萃注射,抱怨兩側的注射部位有結節產生,而且有眼瞼外翻的現象。我們取出了填充劑並討論它造成的影響。材料及方法:一位三十歲女性於兩年前曾接受過淚溝部位的舒顏萃注射,但是結節產生非常明顯。我們呈現處理方式跟討論它產生的併發症。結果:我們使用結膜內開式開刀法在全身麻醉之下進行了手術移除填充物,並將取出之外來物送病理化驗。結論:舒顏萃廣泛應用於臉部脂肪萎縮,但如果應用於眼眶周圍注射的話需要非常的小心,因為併發症可能很明顯。手術移除應是處理此併發症的最後手段但是也是最有效的處理方式。 |
英文摘要 | Background: Sculptra®, a product of poly-L-lactic acid, has been used widely in Europe since 1999, and gained U.S. Food and Drug Administration approval for use in human immunodeficiency virus-related facial lipoatrophy in August 2004. This stimulatory filler was then developed for use in other types of facial-filler procedures in Taiwan. A 30-year-old woman who received Sculptra^® injection for depressed tear-trough grooves complained of both nodular formation and ectropion for two years. We removed the filler, and here we discussed its effect. Materials and Methods: A 30-year-old woman received Sculptra^® injection for 2 years, but nodule formation was prominent. We discuss the management of and complications associated with this filler. Results: Surgery for removal of the filler was performed under general anesthesia. A transconjunctival approach was used to remove foreign bodies, and pathological analysis was achieved. The patient was satisfied with the final outcome. Conclusion: Sculptra^® is widely used for facial lipodystropy. Physicians should focus closely on periorbital injection because complications will be troublesome and disturbing. Surgery should be the ultimate but effective method for management. |
本系統中英文摘要資訊取自各篇刊載內容。